Application 020926
- Type
- NDA
- Sponsor
- GENZYME
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RENAGEL | SEVELAMER HYDROCHLORIDE | CAPSULE;ORAL | 403MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020926-001 | RENAGEL | SEVELAMER HYDROCHLORIDE | 403MG | CAPSULE / ORAL | 1998-10-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020926-001 | RENAGEL | 403MG | CAPSULE / ORAL | 1998-10-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N020926-001 | RENAGEL | 403MG | CAPSULE / ORAL | 1998-10-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020926-001 | RENAGEL | 403MG | CAPSULE / ORAL | 1998-10-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020926-001 | RENAGEL | 403MG | CAPSULE / ORAL | 1998-10-30 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | American Health Packaging | 8830526f-d957-423e-84ea-e4d79346948b | 2026-06-25 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| sevelamer hydrochloride | SEVELAMER HYDROCHLORIDE | Cardinal Health 107, LLC | c13532a7-4c56-4084-839d-3dcfd4dc30f8 | 2026-02-26 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| sevelamer hydrochloride | SEVELAMER HYDROCHLORIDE | Major Pharmaceuticals | 0500034d-458c-42c5-918d-9acd22f0c28b | 2026-02-13 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| sevelamer hydrochloride | SEVELAMER HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | 2cd6512f-0edd-4a30-a4fa-aa996038633c | 2026-01-27 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| Sevelamer hydrochloride | SEVELAMER HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | a56c857e-bc39-484c-908d-f5957857efbb | 2025-07-22 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | Bryant Ranch Prepack | 35337152-9b92-40c0-e063-6294a90a8dd5 | 2025-05-15 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | Bryant Ranch Prepack | 3533d24b-508e-f012-e063-6394a90acaf5 | 2025-05-15 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | ddecb552-5882-4e44-8fa7-37c9234dd1b9 | 2025-02-05 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| SEVELAMER HYDROCHLORIDE | SEVELAMER HYDROCHLORIDE | Aurobindo Pharma Limited | d8729e42-dbbd-4954-9ce0-298743a15a06 | 2024-01-24 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 6926ebbe-2d74-4d5f-b642-c1bfe3a4e305 | 2023-06-05 | Warnings, Adverse reactions | SEVELAMER HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.